Kevin Koch, President and CEO: Edgewise Therapeutics EWTX Sell · Filed 23/05/03

Trade details

Type: Insider sale
Amount: $28,506.7
Shares · price: 3,203 sh · $8.90 a share
Held after: 7,213 sh
Stock: Edgewise Therapeutics EWTX
Person: Kevin KochPresident and CEO
Trade date: 23/05/02
Filed: 23/05/03
Days to filing: 1 days

Sold 30.8% of holdings

Share of holding sold: 30.8%

Edgewise Therapeutics trades, last 26 weeks

What else happened in Edgewise Therapeutics around then

Filed or reported within 30 days of the trade day · 23/04/02~23/06/01

Kevin Koch's recent trades

Kevin KochPresident and CEO
SellEdgewise Therapeutics
Sell
Edgewise Therapeutics
EWTX
$106.7K
7,972 sh
$106.7K
Filed 25/08/14
Traded 25/08/12
Kevin KochPresident and CEO
SellEdgewise Therapeutics
Sell
Edgewise Therapeutics
EWTX
$70.3K
4,276 sh
$70.3K
Filed 25/05/07
Traded 25/05/02
Kevin KochPresident and CEO
Sell10b5-1 planEdgewise Therapeutics
Sell10b5-1 plan
Edgewise Therapeutics
EWTX
$3,000
100 sh
$3,000
Filed 25/03/11
Traded 25/03/07
Kevin KochPresident and CEO
Sell10b5-1 planEdgewise Therapeutics
Sell10b5-1 plan
Edgewise Therapeutics
EWTX
$259.3K
8,636 sh
$259.3K
Filed 25/02/07
Traded 25/02/05
Kevin KochPresident and CEO
Sell10b5-1 planEdgewise Therapeutics
Sell10b5-1 plan
Edgewise Therapeutics
EWTX
$28K
900 sh
$28K
Filed 25/02/07
Traded 25/02/06